ATP Inhibits the Transcription Factor STAT5b. (25th July 2019)

• Record Type: Journal Article
• Authors: Berg, Angela; Sperl, Bianca; Berg, Thorsten
• Is Part Of: Chembiochem. Volume 20:Number 17(2019)
• Page Start: 2227
• Page End: 2231
• Publication Date: 2019-07-25
• Subjects: bioactive compounds -- inhibitors -- nucleotides -- protein–protein interactions -- SH2 domain; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Pharmaceutical chemistry -- Periodicals; 572
• DOI: 10.1002/cbic.201900173
• Languages: English
• ISSNs: 1439-4227

Abstract

Abstract: Although naturally occurring low‐molecular‐weight compounds have many known roles within the cell, these do not usually involve the direct inhibition of protein–protein interactions. Based on the results of high‐throughput screening of a library of bioactive compounds and neurotransmitters, we report here that the four nucleoside triphosphates ATP, GTP, CTP and UTP inhibit the SH2 domain of the tumor‐related transcription factor STAT5b. ATP and GTP are the most active nucleoside triphosphates and show specificity for STAT5b over STAT5a, STAT3, STAT6 and the p53‐binding protein HDM2. As the inhibition constant of ATP against STAT5b is significantly lower than published values for the intracellular ATP concentration, our data suggest that ATP might inhibit the protein–protein interactions of STAT5b in living cells. Abstract : A different side of ATP : ATP is the primary energy carrier of the cell and a co‐substrate for protein kinases. Unexpectedly, ATP also inhibits the protein–protein interaction domain of the tumor‐relevant transcription factor STAT5b at physiologically relevant concentrations.